U.S. Markets close in 2 hrs 7 mins

One World Pharma, Inc. (OWPC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1000+0.0150 (+17.65%)
As of 1:32PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0850
Open0.0975
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0755 - 0.1100
52 Week Range0.0605 - 4.6500
Volume190,084
Avg. Volume41,441
Market Cap5.149M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1800
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • One World’s Dr. Kenneth Perego Joins Montel Williams for Blunt Discussion
    GlobeNewswire

    One World’s Dr. Kenneth Perego Joins Montel Williams for Blunt Discussion

    LAS VEGAS, NV, Oct. 28, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- One World Pharma Inc. (OTC: OWPC), “OWP,” a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce that its Executive Chairman, Dr. Kenneth Perego, recently joined television personality and cannabis advocate Montel Williams on his popular podcast “Let’s Be Blunt.” The podcast is available at the following link.https://letsbebluntmontel.com/episodes/0oilhfl89dqmw9t7hxb9n2mpn1kdhoThe pair discussed One World Pharma’s business model growing cannabis to scale using the equatorial advantages in Colombia and the role of its CEO, the legendary NBA Hall of Famer Isiah Thomas. Dr. Perego discusses the endocannabinoid system, the latest in cannabis research, and why Colombia plays an important role in the future of the cannabis supply chain worldwide.“It’s a true honor to sit down with Montel, a true pioneer, and to share our passion for cannabis, its cultivation, and for making it available to consumers worldwide,” stated Dr. Perego, Executive Chairman, One World Pharma.About One World PharmaFormed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp-derived ingredients for use in the manufacturing of Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia.One World Pharma Investor Relations & Financial MediaKurt Divich, CEOIntegrity Media Inc.team@integritymedia.comToll Free: (888) 216-3595www.IntegrityMedia.comInformation about Forward-Looking StatementsThis press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

  • GlobeNewswire

    One World Pharma Enters Agreement and LOI with BIOTROPICAL for Up to 600,000 Cuttings

    LAS VEGAS, NV, Oct. 16, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – One World Pharma Inc. (OTC: OWPC), “OWP,” a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is pleased to announce that it has entered into an agreement for the sale of 30,000 cuttings from its farms in Colombia. Additionally, the Companies have entered into a Letter of Intent (LOI) for BIOTROPICAL to purchase up to 600,000 cuttings from One World Pharma.A plant cutting is a part of a plant that is used in horticulture for vegetative (asexual) propagation, in this instance cannabis production. Under the terms of the LOI, One World Pharma would purchase the entire harvest from BIOTROPICAL.BIOTROPICAL is a subsidiary of BIOPROTECCION which has been devoted to the research and development in the management of pests and new varieties of cannabis. After the initial 30,000 cuttings, BIOTROPICAL plans to expand its operation up to 600,000 cuttings by the second quarter of 2021. The Company has more than 100 hectares of land available for cannabis production.“We are pleased to partner with BIOTROPICAL to provide them with world-class cannabis cuttings from our genetic portfolio and to purchase this elite harvest,” stated Isiah Thomas, CEO, One World Pharma Inc. “We look forward to assisting with BIOTROPICAL’s production and to assisting them to achieve their goal of purchasing 600,000 cuttings.”“With our production in full-swing, we look forward to more partnerships and sales similar to these,” added Thomas.About One World PharmaFormed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp-derived ingredients for use in the manufacturing of Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for chemical formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia, and a facility in Popayan, Colombia.One World Pharma Investor Relations & Financial Media Kurt Divich, CEO Integrity Media Inc. team@integritymedia.com Toll Free: (888) 216-3595 www.IntegrityMedia.comInformation about Forward-Looking StatementsThis press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company's need for additional funding, the demand for the Company's products, governmental regulation of the cannabis industry, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, risks related to operating in Colombia, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other risks that may be detailed from time-to-time in the Company's filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting One World Pharma, please refer to the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on May 29, 2020, which is available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

  • GlobeNewswire

    Emerging Markets Report: The Tipping Point

    An Emerging Markets News CommentaryORLANDO, Fla., Oct. 07, 2020 (GLOBE NEWSWIRE) -- As regular readers of the Emerging Markets Report know we’re big fans of two things at the small cap level: Transparency and Revenue. And while we argue in-house about which matters more, the reality is no real deal can exist in perpetuity without both being in place. And that’s why we’re now most pleased with some recent developments by Isiah Thomas’s Colombian cannabis producer, One World Pharma Inc. (OTCQB: OWPC).A short while ago, Thomas and team held a zoom Investor Presentation where they covered a myriad of items and took questions from investors. We highly encourage investors to take an opportunity to hear this first-person update on some really important developments for OWP.It’s clear they are at a tipping point.Here’s a link:https://tinyurl.com/y3kalz9n We appreciate Thomas’s transparency and proactivity. It’s more than clear that the legendary athlete is bringing a stellar business background to this cannabis play, most notably his success with Cheurlin Champagnes where a deep relationship with the soil and sun, the people and the plant are also required. Thomas’s hoops background aside, he appears to be very well prepared to lead OWP into what they are calling their ‘first revenue phase.’It’s not going unnoticed. Check out a recent Benzinga feature about Isiah’s path to One World Pharma.But it’s the ‘entering its first revenue phase’ statement that is what we’re really focused on with OWP. It could truly be transformative.There are myriad cannabis plays in public markets. Very few are established in Colombia where Mr. Thomas often extols the “equatorial advantage” in the favorable climate for growing hemp and cannabis at scale.Entering a revenue phase also means that the Company has climbed the logistical mountain of licensing, infrastructure, labor, and seed characterization. A gargantuan task no less.As Isiah explains in the presentation, now comes an opportunity to harvest and sell, to solicit very large customers and grow to spec via its compelling Futures program and to at-last reap the harvest of revenue… from the harvest.So we will continue to follow One World Pharma armed with more clarity about the opportunity, and as the Company at last pursues ever-important revenue from long anticipated harvests.For more information on One World Pharma please visit:www.OneWorldPharma.comAbout One World PharmaFormed in 2017, One World Pharma Inc. (“OWP”) is a fully licensed global supplier of high-quality hemp and cannabis derived ingredients for use in the manufacturing of Medical, Pharmaceutical, Consumer Packaged Goods (CPGs) and Over-the-Counter (OTC) products. OWP offers a reliable and sustainable supply chain for formulators, food & beverage producers as well as beauty product manufacturers worldwide. The company maintains corporate offices in Las Vegas, NV and Bogota Colombia and a facility in Popayan, Colombia.About The Emerging Markets Report:The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.For more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.phpSection 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.DISCLAIMER:EMC has been paid 145,000 dollars and 425,000 restricted shares by One World Pharma. EMC has a contract to receive 40,000 dollars over the next six months. KP Investment partners invested 50,000 dollars in One World Pharma. EMC acquired a unit that translates into shares at .20 and a warrant. CEO of Emerging Markets James Painter has a 50% ownership stake in KP Investment partnersAdditionally, Integrity Media holds 780,000 shares and receives $4,000 a month for a period of twenty-four months for investor relations services on behalf of One World Pharma.http://emergingmarketsllc.com/disclaimer.phpMust Read OTC Markets/SEC policy on stock promotion and investor protection * https://www.otcmarkets.com/learn/policy-on-stock-promotion * https://www.otcmarkets.com/learn/investor-protection * https://www.sec.gov/news/press-release/2017-79 * https://www.sec.gov/oiea/investor-alerts-bulletins/ia_promotions.htmlEmerging Markets Consulting, LLC Florida Office 15701 State Road 50, Suite 205 Clermont, FL 34711 E-mail: jamespainter@emergingmarketsllc.com Web: www.emergingmarketsllc.com